{"id":1013974,"date":"2026-10-27T08:35:27","date_gmt":"2026-10-27T12:35:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/"},"modified":"2026-10-27T08:35:27","modified_gmt":"2026-10-27T12:35:27","slug":"absci-to-participate-in-upcoming-investor-conferences-8","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/","title":{"rendered":"Absci to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">VANCOUVER, Wash. and NEW YORK, Oct.  27, 2026  (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Guggenheim 3<\/strong><br \/>\n          <sup><br \/>\n            <strong>rd<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Healthcare Innovation Conference (Boston, MA)<br \/><\/strong>Fireside chat on Tuesday, November 10<sup>th<\/sup> at 1:00 p.m. Eastern Time \/ 10:00 a.m. Pacific Time<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>2026 Jefferies Global Healthcare Conference (London, England)<br \/><\/strong>Fireside chat on Wednesday, November 18<sup>th<\/sup> at 3:00 p.m. Greenwich Mean Time \/ 10:00 a.m. Eastern Time<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>9<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Evercore Healthcare Conference (Coral Gables, FL)<br \/><\/strong>Fireside chat on Tuesday, December 1<sup>st<\/sup> at 7:30 a.m. Eastern Time \/ 4:30 a.m. Pacific Time<\/li>\n<\/ul>\n<p align=\"justify\">Interested parties may access live and archived webcasts of the fireside chat sessions on the company\u2019s investor relations website at: investors.absci.com.<\/p>\n<p align=\"justify\">\n        <strong>About Absci<\/strong>\n      <\/p>\n<p align=\"justify\">Absci is advancing the future of drug discovery with generative design to create better biologics for patients, faster. Our Integrated Drug Creation\u2122 platform combines cutting-edge AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci\u2019s approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Each cycle refines our data and strengthens our models, facilitating rapid innovation and enhancing the precision of our therapeutic designs. Alongside collaborations with top pharmaceutical, biotech, tech, and academic leaders, Absci is advancing its own pipeline of AI designed therapeutics including ABS-201\u2122, a groundbreaking innovation in hair regrowth with the potential to redefine treatment possibilities for pattern hair loss. ABS-201 is also being investigated as a potential \u201cbest-in-class\u201d therapeutic for endometriosis, a condition with significant unmet medical need and market potential. Absci is headquartered in Vancouver, WA, with AI Research Labs in New York City and Serbia, and an Innovation Center in Switzerland. Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wE4YkpJ8K8ozeYdO55WlVrWC1_HS8gWacQWk4riy_2SX6Ql5-kQeVRbGvHWpn-1AUVS6reg4jI2XWTU8pvUuVA==\" rel=\"nofollow\" target=\"_blank\"><u>www.absci.com<\/u><\/a> or follow us on LinkedIn (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_wTE_OGO9D5osrB_Q9IjSTNUMKp5fkjPO-X-uSvtBnhgC1zOwIFqeDNnlCkWz_6ubJh5T1NSNHUDui-3aEZck_3ut91la3z-JW_-zbsRq6c=\" rel=\"nofollow\" target=\"_blank\"><u>@absci<\/u><\/a>), X (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F07NaKOMPsgNRVzR7lJZSsUBE_uDdsvvVg53pufMmBsehSCYESwvywuVEFw163FG_OoPKMsW-SDs5xKwQLf1tA==\" rel=\"nofollow\" target=\"_blank\"><u>@Abscibio<\/u><\/a>) and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vPp3p06430jQafBfwKBJSNGEru-xEFGEpeTdHnc5DExv09aT-jJaMvvvm8FRzcVWQF59PqiN1emC8CkJOY3JSyWaKjAt4ZayPZw2sb4eDvA=\" rel=\"nofollow\" target=\"_blank\"><u>YouTube<\/u><\/a>.<\/p>\n<p align=\"justify\">Absci<sup>\u00ae<\/sup> standard character mark, ABS-201\u2122, and Integrated Drug Creation\u2122 are trademarks and registered trademarks of Absci Corporation.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Alexander D.H. Khan<br \/>Corporate Vice President<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mNrLB8a_JacEg3JuZkjZaQpxbQY4_T-VHwL0KSyjCH9skWnb5NhWyJ-wjLhO97jo0fr-7ZBwKtuCCACBNFRez7ImC9e6uY9U-lDKV-O3JsQ=\" rel=\"nofollow\" target=\"_blank\">investors@absci.com<\/a>\u00a0<\/p>\n<p align=\"justify\">\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cgYeCHNsxP3w3Y9uOlZlHg2dH9W9r81enZ-WaXQ9j6-9EYUKDN4lgh-Jut6aufwuZo4z5Fjht__KblwYzu6wog==\" rel=\"nofollow\" target=\"_blank\">press@absci.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTAzZmQwMTYtMTI1OC00NzA4LWFjZWEtN2RhMDg2NzVkZmJhLTEyMjE2MzMtMjAyNi0xMC0yNy1lbg==\/tiny\/ABSCI-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, Wash. and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences: Guggenheim 3 rd Annual Healthcare Innovation Conference (Boston, MA)Fireside chat on Tuesday, November 10th at 1:00 p.m. Eastern Time \/ 10:00 a.m. Pacific Time 2026 Jefferies Global Healthcare Conference (London, England)Fireside chat on Wednesday, November 18th at 3:00 p.m. Greenwich Mean Time \/ 10:00 a.m. Eastern Time 9 th Annual Evercore Healthcare Conference (Coral Gables, FL)Fireside chat on Tuesday, December 1st at 7:30 a.m. Eastern Time \/ 4:30 a.m. Pacific Time Interested parties may access live and archived webcasts of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Absci to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1013974","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Absci to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Absci to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, Wash. and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences: Guggenheim 3 rd Annual Healthcare Innovation Conference (Boston, MA)Fireside chat on Tuesday, November 10th at 1:00 p.m. Eastern Time \/ 10:00 a.m. Pacific Time 2026 Jefferies Global Healthcare Conference (London, England)Fireside chat on Wednesday, November 18th at 3:00 p.m. Greenwich Mean Time \/ 10:00 a.m. Eastern Time 9 th Annual Evercore Healthcare Conference (Coral Gables, FL)Fireside chat on Tuesday, December 1st at 7:30 a.m. Eastern Time \/ 4:30 a.m. Pacific Time Interested parties may access live and archived webcasts of the &hellip; Continue reading &quot;Absci to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-27T12:35:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Absci to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-10-27T12:35:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/\"},\"wordCount\":354,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/\",\"name\":\"Absci to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=\",\"datePublished\":\"2026-10-27T12:35:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-participate-in-upcoming-investor-conferences-8\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Absci to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Absci to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/","og_locale":"en_US","og_type":"article","og_title":"Absci to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"VANCOUVER, Wash. and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences: Guggenheim 3 rd Annual Healthcare Innovation Conference (Boston, MA)Fireside chat on Tuesday, November 10th at 1:00 p.m. Eastern Time \/ 10:00 a.m. Pacific Time 2026 Jefferies Global Healthcare Conference (London, England)Fireside chat on Wednesday, November 18th at 3:00 p.m. Greenwich Mean Time \/ 10:00 a.m. Eastern Time 9 th Annual Evercore Healthcare Conference (Coral Gables, FL)Fireside chat on Tuesday, December 1st at 7:30 a.m. Eastern Time \/ 4:30 a.m. Pacific Time Interested parties may access live and archived webcasts of the &hellip; Continue reading \"Absci to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-27T12:35:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Absci to Participate in Upcoming Investor Conferences","datePublished":"2026-10-27T12:35:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/"},"wordCount":354,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/","name":"Absci to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=","datePublished":"2026-10-27T12:35:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjAyMCM3OTEyOTM2IzIyMTAwODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-participate-in-upcoming-investor-conferences-8\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Absci to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1013974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1013974"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1013974\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1013974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1013974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1013974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}